14
Participants
Start Date
October 27, 2023
Primary Completion Date
February 1, 2024
Study Completion Date
February 1, 2026
Unrelated Umbilical Cord Blood
The requirements of unrelated umbilical cord blood: recipient-donor HLA match is 0-3/10, same blood type.
Venetoclax
Patients will be treated with Venetoclax (100 mg on day 1, 200 mg on day 2 and 400 mg on days 3 to 21)
Decetabine
Patients will be treated with Decetabine (20mg/m\^2/d on days 1 to 5) or Azacitidine (75mg/m\^2/d on days 1 to 7)
Azacitidine
Patients will be treated with Decetabine (20mg/m\^2/d on days 1 to 5) or Azacitidine (75mg/m\^2/d on days 1 to 7)
RECRUITING
The First Affiliated Hospital of University of Science and Technology of China, Hefei
Anhui Provincial Hospital
OTHER_GOV